Stockholders (Deficit) Equity - Equity Offering and Warrant issuance (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
	Dec. 28, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 27, 2023
Stockholders' Equity
Common stock authorized (in shares)		200,000,000		200,000,000		200,000,000
Preferred stock authorized (in shares)		5,000,000		5,000,000		5,000,000
Number of shares that can be purchased upon exercise of warrants (in shares)		354,100		354,100
Change in fair value of warrant liability		$ 441	$ 682	$ 4,624	$ 2,385
December 2023 Equity Offering and Warrant Issuance
Stockholders' Equity
Number of shares that can be purchased upon exercise of warrants (in shares)		345,946		345,946
Exercise price (in dollars per share)		$ 17.50		$ 17.50
Change in fair value of warrant liability				$ 4,624
December 2023 Equity Offering and Warrant Issuance | Common Stock Warrants
Stockholders' Equity
Number of shares that can be purchased upon exercise of warrants (in shares)	111,196
Exercise price (in dollars per share)	$ 17.50
December 2023 Equity Offering and Warrant Issuance | Pre-funded Common Stock Warrants
Stockholders' Equity
Number of shares that can be purchased upon exercise of warrants (in shares)	111,196
Warrant price (in dollars per share)	$ 17.50
Exercise price (in dollars per share)	$ 0.025
December 2023 Inducement Agreement
Stockholders' Equity
Number of warrants held by investor (in shares)	117,375
Number of warrants exercised held in abeyance (in shares)	49,375
Exercise price (in dollars per share)	$ 17.50						$ 83.75
Granted (in shares)	234,750
Change in fair value of warrant liability	$ 4,200
Proceeds from sale of pre-funded warrants and exercise of warrants	$ 3,500